CR20140345A - Nuevas formas y sales de un dihidropirrolo [1,2-c] imidazolilo, inhibidor de la aldosterona sintasa o aromatasa - Google Patents

Nuevas formas y sales de un dihidropirrolo [1,2-c] imidazolilo, inhibidor de la aldosterona sintasa o aromatasa

Info

Publication number
CR20140345A
CR20140345A CR20140345A CR20140345A CR20140345A CR 20140345 A CR20140345 A CR 20140345A CR 20140345 A CR20140345 A CR 20140345A CR 20140345 A CR20140345 A CR 20140345A CR 20140345 A CR20140345 A CR 20140345A
Authority
CR
Costa Rica
Prior art keywords
salts
imidazolilo
dihydropirrolo
sintasa
aldosterone
Prior art date
Application number
CR20140345A
Other languages
English (en)
Inventor
Paul Sutton
Eric Loeser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47604250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20140345(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CR20140345A publication Critical patent/CR20140345A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención se refiere a una sal de fosfato o una sal de nitrato de 4 - (R) - 6,7- dihidro-5H- pirrolo [1,2- c] imidazol- 5- il- 3- fluoro- benzonitrilo, con la siguiente fórmula: especialmente en forma cristalina, y formas específicas de estas sales, a
CR20140345A 2012-01-17 2014-07-17 Nuevas formas y sales de un dihidropirrolo [1,2-c] imidazolilo, inhibidor de la aldosterona sintasa o aromatasa CR20140345A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261587280P 2012-01-17 2012-01-17

Publications (1)

Publication Number Publication Date
CR20140345A true CR20140345A (es) 2014-09-09

Family

ID=47604250

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140345A CR20140345A (es) 2012-01-17 2014-07-17 Nuevas formas y sales de un dihidropirrolo [1,2-c] imidazolilo, inhibidor de la aldosterona sintasa o aromatasa

Country Status (40)

Country Link
US (2) US9334276B2 (es)
EP (1) EP2804863B1 (es)
JP (1) JP5749410B2 (es)
KR (2) KR20140093726A (es)
CN (1) CN104039793B (es)
AP (1) AP2014007762A0 (es)
AR (1) AR089728A1 (es)
AU (1) AU2013209952B2 (es)
BR (1) BR112014017260A8 (es)
CA (1) CA2863339C (es)
CL (1) CL2014001863A1 (es)
CO (1) CO7000775A2 (es)
CR (1) CR20140345A (es)
CU (1) CU20140086A7 (es)
CY (1) CY1117914T1 (es)
DK (1) DK2804863T3 (es)
EA (1) EA026232B1 (es)
ES (1) ES2564143T3 (es)
GT (1) GT201400155A (es)
HR (1) HRP20160178T1 (es)
HU (1) HUE026984T2 (es)
IL (1) IL233541B (es)
IN (1) IN2014DN06781A (es)
JO (1) JO3137B1 (es)
MA (1) MA35858B1 (es)
MX (1) MX2014008686A (es)
NZ (1) NZ626277A (es)
PE (1) PE20142358A1 (es)
PH (1) PH12014501638A1 (es)
PL (1) PL2804863T3 (es)
RS (1) RS54589B1 (es)
SG (1) SG11201404061YA (es)
SI (1) SI2804863T1 (es)
SM (1) SMT201600083B (es)
TN (1) TN2014000256A1 (es)
TW (1) TWI609869B (es)
UA (1) UA114803C2 (es)
UY (1) UY34576A (es)
WO (1) WO2013109514A1 (es)
ZA (1) ZA201404314B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011205290C1 (en) * 2010-01-14 2014-11-06 Recordati Ag Use of an adrenal hormone-modifying agent
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
SI3166596T1 (sl) * 2014-07-07 2018-10-30 Novartis Ag Farmacevtske odmerne oblike
HUE054248T2 (hu) 2015-01-29 2021-08-30 Recordati Ag Eljárás kondenzált imidazo-származékok elõállítására
US20160287565A1 (en) * 2015-04-06 2016-10-06 Millendo Therapeutics, Inc. Combination therapy for treating disorders associated with excess cortisol production
EP3532056A1 (en) * 2016-10-27 2019-09-04 Damian Pharma AG Aldosterone synthase inhibitor
WO2018078049A1 (en) * 2016-10-27 2018-05-03 Damian Pharma Ag Aldosterone synthase inhibitor
WO2019211394A1 (en) 2018-05-03 2019-11-07 Damian Pharma Ag R-fadrozole for use in the treatment of aldostonerism

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1315449A (en) * 1918-11-15 1919-09-09 Frank B Yingling Shaper-feed.
US4617307A (en) 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5066656A (en) 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
MTP1076B (en) 1990-01-12 1991-09-30 Ciba Geigy Ag Hemihydrate
CA2127689A1 (en) 1992-01-27 1993-08-05 Marcel A. C. Janssen Pyrroloimidazolyl and imidazopyridinyl substituted 1h-benzimidazole derivatives as aromatase inhibitors
CA2505752A1 (en) 2002-11-18 2004-06-03 Novartis Ag Imidazo[1,5a]pyridine derivatives and methods for treating aldosterone mediated diseases
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
CN101578272A (zh) 2006-12-18 2009-11-11 诺瓦提斯公司 1-取代的咪唑衍生物和它们作为醛固酮合酶抑制剂的用途
US8575160B2 (en) 2009-11-30 2013-11-05 Novartis Ag Imidazole derivatives as aldosterone synthase inhibitors
AU2011205290C1 (en) * 2010-01-14 2014-11-06 Recordati Ag Use of an adrenal hormone-modifying agent

Also Published As

Publication number Publication date
HRP20160178T1 (hr) 2016-03-25
TN2014000256A1 (en) 2015-09-30
JO3137B1 (ar) 2017-09-20
JP5749410B2 (ja) 2015-07-15
PH12014501638B1 (en) 2014-10-13
NZ626277A (en) 2015-10-30
CO7000775A2 (es) 2014-07-21
CU20140086A7 (es) 2014-12-26
IL233541A0 (en) 2014-08-31
IL233541B (en) 2018-12-31
PL2804863T3 (pl) 2016-06-30
RS54589B1 (sr) 2016-08-31
PE20142358A1 (es) 2015-01-30
BR112014017260A2 (pt) 2017-06-13
MX2014008686A (es) 2014-08-27
TWI609869B (zh) 2018-01-01
EP2804863B1 (en) 2015-12-02
ES2564143T8 (es) 2020-11-18
US20140364470A1 (en) 2014-12-11
AU2013209952A1 (en) 2014-07-24
EP2804863A1 (en) 2014-11-26
JP2015503627A (ja) 2015-02-02
UA114803C2 (uk) 2017-08-10
ES2564143T3 (es) 2016-03-18
AU2013209952B2 (en) 2016-09-01
CL2014001863A1 (es) 2014-11-07
UY34576A (es) 2013-09-02
CY1117914T1 (el) 2017-05-17
SG11201404061YA (en) 2014-08-28
EA026232B1 (ru) 2017-03-31
AR089728A1 (es) 2014-09-10
US20160176883A1 (en) 2016-06-23
CA2863339C (en) 2021-03-23
SI2804863T1 (sl) 2016-05-31
GT201400155A (es) 2017-09-28
IN2014DN06781A (es) 2015-05-22
DK2804863T3 (en) 2016-03-07
US9334276B2 (en) 2016-05-10
KR20140093726A (ko) 2014-07-28
EA201491374A1 (ru) 2014-12-30
PH12014501638A1 (en) 2014-10-13
ZA201404314B (en) 2015-08-26
CA2863339A1 (en) 2013-07-25
WO2013109514A1 (en) 2013-07-25
SMT201600083B (it) 2016-04-29
BR112014017260A8 (pt) 2017-07-04
CN104039793B (zh) 2017-05-10
HUE026984T2 (en) 2016-08-29
HK1198536A1 (en) 2015-05-15
AP2014007762A0 (en) 2014-07-31
KR20140141687A (ko) 2014-12-10
CN104039793A (zh) 2014-09-10
MA35858B1 (fr) 2014-12-01
TW201335161A (zh) 2013-09-01

Similar Documents

Publication Publication Date Title
UY33985A (es) Sales de 2,3-dihidroimidazo [1,2-c] quinazolina sustituida
SMT201600023B (it) Composti piridazinonici e loro uso come inibitori di daao
SG11201504540TA (en) NEW BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS
EP2788000A4 (en) PYRROLOPYRIMIDINES AS JANUSKINASEINHIBITORS
HUE055618T2 (hu) 2-amino-N-(piperidin-1-il-piridin-3-il)-pirazolo-[1,5-alfa]-pirimidin-3-karboxamid, mint atr-kináz inhibítoraként használható vegyület
SMT201500265B (it) Composti di pirrolopirimidina quali inibitori di cdk4/6
UY34004A (es) INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO[2,3-d]PIRIMIDINA TROPOMIOSINA
BR112013025354A2 (pt) combinações de compostos de inibidor de akt e agentes quimioterápicos e métodos de uso
EP2934535A4 (en) SUBSTITUTED PYRROLOPYRIMIDINES AS HDM2 INHIBITORS
SMT201400106B (it) Inibitori di met per incrementare l'efficacia della radioterapia
PL2790705T3 (pl) Zastosowanie inhibitorów czynności lub funkcji PI3K
CU20140086A7 (es) NUEVAS FORMAS Y SALES DE UN DIHIDROPIRROLO [1,2-c] IMIDAZOLILO, INHIBIDOR DE LA ALDOSTERONA SINTASA O AROMATASA
PL2804861T3 (pl) Podstawione związki pirymidyny i ich zastosowanie jako inhibitory SYK
MA35439B1 (fr) Inhibiteurs de l'enzyme activant nedd8
EP2714967A4 (en) ANTI-CORROSIVE ELECTROCOATING
MX359673B (es) Preparacion de intermediarios de pirimidina utiles para la preparacion de maci tentano.
MX346678B (es) Sales de arginina utiles inmunologicamente.
ITUD20110217A1 (it) Apparato per l'incasso di una bobina e valvola idraulica azionata a pilota che incorpora lo stesso
IL236630B (en) Urea compounds and their use as enzyme inhibitors
IL237626A0 (en) Novel inhibitory compounds of type a10 phosphodiesterase
EP3063312A4 (en) The use of niobate containing compounds as corrosion inhibitors
MX373441B (es) Derivados de indol-urea glucopiranosil-sustituido y su uso como inhibidores sglt.
SG11201504115XA (en) Novel inhibitor compounds of phosphodiesterase type 10a
UA106105C2 (uk) Застосування похідних 2-оксоіндолін-3-гліоксилової кислоти як засобів з антидепресивною дією
UY33803A (es) Formas de dosificación de liberación modificada novedosas de inhibidor de xantina oxidorreductasa o inhibidores de xantina oxidasa